MedTrace Logo

A Pilot Study of a PhysiOthErapy-based Tailored Intervention for Long COVID (COVID-19)

NCT05040893 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-08-29

No results posted yet for this study

Summary

The purpose of this study is to determine the benefits and feasibility of physiotherapy in the recovery of ongoing symptoms after COVID-19 illness. Long COVID Syndrome (Long COVID) is defined by persistent symptoms (including breathlessness, chest pain and fatigue) after COVID-19 illness that continue for more than 12 weeks and cannot be explained by another diagnosis. The goal of this project is to explore physiotherapy as treatment for patients suffering from Long COVID.

Conditions

Interventions

BEHAVIORAL

Physiotherapy

Interventions will include: 1. Education and self-management strategies, including the use of wearable activity and real-time heart rate monitors, to safely guide pacing and activity. 2. Breathing pattern education and retraining (including diaphragmatic, relaxed, and paced breathing exercises). 3. Return-to-activity exercise programming (e.g., postural, aerobic, and whole-body strengthening exercises).

Sponsors & Collaborators

  • Alberta Health services

    collaborator OTHER

  • University of Calgary

    lead OTHER

Principal Investigators

  • Jason Weatherald, MD, MSc · University of Calgary

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-04
Primary Completion
2023-08-09
Completion
2023-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05040893 on ClinicalTrials.gov